Today, an analyst has provided a rating update for the Financial sector company, Cronos Group Inc (TSXV: CRON). Analyst Martin Landry from GMP FirstEnergy rated Cronos Group Inc (TSXV: CRON) a Buy, setting a C$10 price target.
Landry has an average return of 71.6% when recommending Cronos Group Inc.
According to TipRanks.com, Landry is ranked #79 out of 4850 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Cronos Group Inc with a C$8.25 average price target.
The company has a one-year high of C$14.83 and a one-year low of C$2.01. Currently, Cronos Group Inc has an average volume of 446K.
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
The company’s shares closed on Friday at C$7.84.
